Therapeutics
-
Spine
InVivo Therapeutics touts case study in 1st spine scaffold implant
JUNE 24, 2016 – BY BRAD PERRIELLO InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of…
Read More » -
Biologics
Stem Cell Pioneer, Celltex Therapeutics, Announces Sponsorship of Regenera Global Conference
HOUSTON (PRWEB) JUNE 17, 2016 Houston-based biotechnology company and adult stem cell pioneer, Celltex Therapeutics Corporation, is proud to announce…
Read More » -
Financial
Flexion Therapeutics Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., June 07, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten…
Read More » -
Extremities
Anika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Hospitals
Bone Therapeutics announces further positive efficacy in ALLOB® Phase I/IIA delayed-union fracture trial
May 17, 2016 BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high…
Read More » -
Spine
Bone Therapeutics completes recruitment of its ALLOB® Phase IIA spinal fusion study
BONE THERAPEUTICS, (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Osiris to Present 15 Advanced Clinical and Scientific Abstracts
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to…
Read More » -
Financial
Bone Therapeutics Reports Full Year 2015 Results
GOSSELIES, Belgium–(BUSINESS WIRE)– Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing…
Read More » -
Biologics
Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Extremities
Anika Therapeutics Wins CE Mark Approval for Cingal® for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Hospitals
Osiris Therapeutics : receives deficiency notice from Nasdaq
March 23–Osiris Therapeutics Inc., the troubled Columbia-based biotechnology firm that saw its CEO resign last month, said Tuesday it has…
Read More »